Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.
about
Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in RwandaPrevention of vertical transmission of HIV-1 in resource-limited settingsThe spread, treatment, and prevention of HIV-1: evolution of a global pandemicEstimating health workforce needs for antiretroviral therapy in resource-limited settingsEngaging HIV care providers in conversations with their reproductive-age patients about fertility desires and intentions: a historical review of the HIV epidemic in the United StatesIs protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysisCare of the HIV-infected pregnant woman in the developed worldThe renaissance of fixed dose combinations: CombivirEffects of Zidovudine Treatment on Heart mRNA Expression and Mitochondrial DNA Copy Number Associated with Alterations in Deoxynucleoside Triphosphate Composition in a Neonatal Rat ModelWhat will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisTransplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine.Measuring coverage in MNCH: population HIV-free survival among children under two years of age in four African countriesSafety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infantsAssociation between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIVA Road Map for 21st Century Genetic Restoration: Gene Pool Enrichment of the Black-Footed FerretProviders caring for adolescents with perinatally-acquired HIV: Current practices and barriers to communication about sexual and reproductive healthGetting to 90-90-90 in paediatric HIV: What is needed?Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model.Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy.Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and IrAntiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infantsAntiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.Evaluation of Medication-mediated Effects in Pharmacoepidemiology.Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive womenImplications of gender and pregnancy for antiretroviral drug dosingDecreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.Identifying factors associated with the uptake of prevention of mother to child HIV transmission programme in Tigray region, Ethiopia: a multilevel modeling approach.Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe.Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment servicesCounselling at primary health facilities and level of knowledge of antenatal attendees and their attitude on prevention of Mother to Child Transmission of HIV in Dar-es salaam, Tanzania.Risk factors associated with low CD4+ lymphocyte count among HIV-positive pregnant women in NigeriaTiming and determinants of mother-to-child transmission of HIV in Nigeria.Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conceptionDifferential bidirectional transfer of indinavir in the isolated perfused human placenta.Risk factors of HIV-1 vertical transmission (VT) and the influence of antiretroviral therapy (ART) in pregnancy outcome.Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention.
P2860
Q21034187-D2B33819-DB1C-40E2-9B49-D3F3819E3583Q22241479-2E635B19-84D5-49DF-9D3C-98E13BDD5D0EQ22241890-FE60008B-A1B5-42A7-A9BE-8314428F48A6Q25256847-5F642EB5-5495-4EE4-B312-D869A0D01440Q26829472-85E6B77D-E398-4CEA-91BF-7DE092769ACAQ28066290-52B70641-FD19-4205-85C8-154A9FA6E0AFQ28082774-E43ED939-B4A4-4F57-BFD7-8B1ED1F565B4Q28279752-06C60E3F-B1D9-4894-BFFF-CEEC40A08D77Q28389095-4D81A2E5-CF98-40B1-9C84-4DE4747498A4Q28478769-B37248BA-4055-442F-A35C-E92B2059046AQ28486041-33F4E64D-2283-44A7-B968-C5778D0BE601Q28487673-37BF746F-2A57-4502-9232-75E2023FCE5AQ28538275-4DB848FF-11A8-49A2-8219-71CEE789865AQ28538279-94DE339D-45E0-4248-B059-684AD6EDB33FQ28546081-CBAFA24A-7624-4087-942A-67EF0A9A63BBQ28607746-AF6C7551-830D-43C3-8937-0B5EA32CE1F9Q30303144-A62F30E5-9496-4916-AE1B-E80DD39B1C2CQ30385352-16BFABDC-5A4F-4332-B2F5-454EAC4A863FQ30395163-E1787016-667F-4BEE-833F-BB33A6F857E7Q31033395-C24D13A3-AF9B-4DFB-B403-320092A77CF7Q31043161-65D12E15-F064-467E-A0A1-9A6E5C3DCB4CQ33294899-B0735F1F-1903-4653-ADBF-0696CFF55690Q33396950-AE9AE53F-8237-4485-96BF-0D83772B33D9Q33501735-7D050FB5-4709-4831-817C-2B81BECBFC25Q33557870-13B228FE-6DD2-4826-B975-B95F5641F466Q33563439-48412DC3-2808-40FC-A02E-FB2A7414845EQ33584069-AED99E38-6154-475B-BBED-6E8BD9BA5BD4Q33604727-978E7D19-B8D0-4525-9204-F4E358E56CB8Q33617634-03592B9A-542C-4702-B1FE-EB8CCBEA724AQ33660894-BE79BAF0-A1C8-4CAF-A4FD-6327B534A7CCQ33705707-974DD825-0231-44C3-9D43-D30586CA8373Q33747752-5E3464A2-F1FE-4822-87FD-F0B5C326AF81Q33751535-3326E01C-7B2F-4E77-B7C2-841E6544B482Q33764938-6B1CEBB8-0919-42BF-A7D0-FC9929371ACFQ33769871-ED2E5FFC-94D3-4F7A-A2C0-C6FAC101038FQ33811876-986DAA8B-B755-4A79-A66F-7EE5104E49F8Q33830084-0C389490-7627-430D-8689-4BF496EF9E29Q33857508-CC725C34-01A2-471F-8C67-7ECDDDC472B4Q33859660-E9108638-BDEA-4F4C-9E90-F2BA2ED24B61Q33888718-8578C069-0496-4355-B932-825BC055C12C
P2860
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Combination antiretroviral str ...... perinatal HIV-1 transmission.
@ast
Combination antiretroviral str ...... perinatal HIV-1 transmission.
@en
type
label
Combination antiretroviral str ...... perinatal HIV-1 transmission.
@ast
Combination antiretroviral str ...... perinatal HIV-1 transmission.
@en
prefLabel
Combination antiretroviral str ...... perinatal HIV-1 transmission.
@ast
Combination antiretroviral str ...... perinatal HIV-1 transmission.
@en
P2093
P921
P1476
Combination antiretroviral str ...... perinatal HIV-1 transmission.
@en
P2093
Clemente Diaz
Edward Handelsman
Ellen R Cooper
I Celine Hanson
Karen Hayani
Lynne Mofenson
Manhattan Charurat
Rodney Hoff
Vincent Smeriglio
P304
P356
10.1097/00126334-200204150-00009
P407
P577
2002-04-01T00:00:00Z